Monica Otto

Government, Health and Not for Profit


Latest publications

TARANTOLA A., OTTO M., ARMENI P., Costa F., MALANDRINI F., JOMMI C. Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case Journal of Pharmaceutical Policy and Practice, 2023, vol.16, no. 1
JOMMI C., BERTOLANI A., ARMENI P., COSTA F., OTTO M. Pharmaceutical pricing and managed entry agreements: an exploratory study on future perspectives in Europe Health Policy and Technology, 2023, pp.100771
FERRARA L., OTTO M., Aapro M., Albreht T., Jonsson B., Oberst S., Oliver K., Pisani E., Presti P., Rubio I. T., Terkola R., TARRICONE R. How to improve efficiency in cancer care: Dimensions, methods, and areas of evaluation Journal of Cancer Policy, 2022, vol.34, pp.100355
JOMMI C., ARMENI P., BERTOLANI A., COSTA F., OTTO M. The future of Funds for Innovative Medicines: results from a Delphi Study Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2021, vol.8, pp.22-28
JOMMI C., ARMENI P., COSTA F., BERTOLANI A., OTTO M. Implementation of Value-based Pricing for Medicines Clinical Therapeutics, 2020, vol.42, no. 1, pp.15-24
OTTO M., ARMENI P., JOMMI C. Variations in non-prescription drug consumption and expenditure: Determinants and policy implications Health Policy, 2018, vol.122, no. 6, pp.614-620

Related Articles

Hospital Management during pandemic crisis: Lessons Learn...
Required time 1 hour